Navigation Links
Reportlinker Adds The Drug-Eluting Stent Market Outlook to 2016

NEW YORK, May 26, 2011 /PRNewswire/ -- announces that a new market research report is available in its catalogue:

The Drug-Eluting Stent Market Outlook to 2016


The DES market has seen tremendous growth since the introduction of DES in 2003, but the market suffered setbacks in 2007 on the release of clinical data that indicated a link to increased thrombosis. Sales of DES have since stabilized owing to the introduction of novel stents with proven superior therapeutic properties over the traditional bare metal stent.

Features and benefits

* Assess the major market trends including mergers and acquisitions, and licensing agreements and their impact on the market.

* Identify the growth strategies of the leading market players and their likely impact on the future DES market.

* Identify key innovations that will shape the DES market of the future.

* Gain insight into the influence of the emerging economies in determining the present and future DES market size.

* Identify emerging companies that are likely to compete in the near future with the leading DES manufacturers.


The DES market has been traditionally characterized by low levels of innovation. However, with the shift in hospital purchasing models from the current sole-supplier model to the capitation pricing model, innovative products are the only ones likely to command premium prices. Thus, this will increase the level of innovation in this segment.

The DES markets in India and China are set to undergo growth in the next five years, concurrent with the improvement of the economies of these two countries and the introduction of the 'Healthy China 2020' plan. However, leading players face stiff competition from local companies in these regions.

Hospitals are currently entering into preferred-supplier agreements whereby they source their medical device requirements from one or two preferred suppliers to leverage volume-based discounts. This puts large suppliers such as Boston Scientific in an advantageous position as they can cater to consolidated spend categories.

Your Key questions answered

* What are the innovations being made in DES technology which of these offers significant potential for future growth?

* What are the key industry trends in terms of mergers and acquisitions and contractual and licensing agreements between buyers and suppliers?

* What are the key regulations in the DES segment and what is the possible impact of new DES technology on the product approval process?

* How have the leading players built a strong position in the DES market and what are their future growth strategies?

* Who are the emerging players in the DES market, what threat do they pose, and what are their business expansion strategies?


Executive Summary

About Business Insights


Overview of the global drug-eluting stents market

DES market landscape

Innovations in the DES market

Key players in the DES market

Overview of the global drug-eluting stents market



Position of DES within the cardiac device market

Evolution of DES

Advantage of DES

Market size and forecasts of DES

Historical market size and forecasts

Geographical segmentation

Epidemiology of major cardiovascular diseases

Adoption trends in cardiovascular procedures

Growth drivers

Increased adoption by physicians owing to prevention of late in-stent restenosis

Decreased need for repeat procedures

Demographics – rise in the mean age of the population

Lifestyle changes – increased prevalence of obesity

Growth resistors

High cost of DES compared with BMS

Release of adverse clinical data pertaining to late stent thrombosis

Release of COURAGE data indicating no significant advantage of DES over BMS

Problems associated with Medicare reimbursement of DES

Regulatory changes impacting the DES market

DES market landscape



Market trends

Mergers and acquisitions

Important mergers and acquisitions by leading players

Mergers, acquisitions, and co-exclusivity agreements among emerging players

Preferred supplier agreements

Increased importance of emerging countries

Pricing of DES

Historical prices of DES and trends

Future trends in pricing

Pricing in emerging economies

US Medicare Part A reimbursement costs of DES

Cost-effectiveness of DES versus BMS

Licensing agreements between pharmaceutical companies and DES manufacturers

Innovations in the DES market



Factors driving innovation

Major innovations

Innovations in the polymer component of DES

Drug-coated balloons

Bifurcation stenting

Self-expandable DES

Development of DES with a two-drug offering

Drugs used in DES

New product approvals

FDA approvals

CE mark approvals


Nevo sirolimus-eluting stent (Johnson & Johnson)

Promus and Taxus everolimus-eluting element stents (Boston Scientific)

Taxus Petal paclitaxel-eluting stent (Boston Scientific)

Odyssey (Boston Scientific)

XIENCE Nano (Abbott labs)

Protex coronary stent system (Nexeon MedSystems)

CoroflexDEBlue stent (B. Braun Melsungen)

Key players in the DES market



Relative positioning of the leading market participants

Boston Scientific

Abbott Laboratories

Cordis (Johnson & Johnson)


Product growth and share snapshot

Emerging players

Relative positioning of the emerging market participants

Opto Circuits

Sahajanand Medical Technologies

Blue Medical Devices

Biosensors International


MicroPort Scientific

Orbus-Neich Medical






To order this report:

Drug Delivery Technology Industry: The Drug-Eluting Stent Market Outlook to 2016

Drug Delivery Technology Business News

More  Market Research Report

Check our  Company Profile, SWOT and Revenue Analysis!

Nicolas Bombourg



US: (805)652-2626

Intl: +1 805-652-2626

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Reportlinker Adds The Infusion Pump Market Outlook to 2016
2. Reportlinker Adds Specialty Pharmaceutical Industry - 2011 Yearbook
3. Reportlinker Adds Advances in Drug-Diagnostic Co-Development
4. Reportlinker Adds Time and Cost Reduction in Clinical Trials- Outsourcing and IT to Optimize Patient Recruitment, Logistics, Data and Site Management
5. Reportlinker Adds Opioids Market to 2017 - Steady Uptake of Oxycontin and High Incidence Of Diseases Such As Cancer And Arthritis to Drive the Market
6. Reportlinker Adds Risk Evaluation and Mitigation Strategy (REMS) - Opioids, Erythropoesis-Stimulating Agents and Cancer Therapeutics are the Most Important Classes That Require REMS
7. Reportlinker Adds Global: Pharmaceuticals Industry Guide
8. Reportlinker Adds Saxagliptin - Key patent, SPC, and data exclusivity expiry (44 country coverage)
9. Reportlinker Adds Generic Pharmaceuticals Industry - Top 200 Generic Pharmaceuticals Industry (Global)
10. Reportlinker Adds Drug Delivery Devices Market Outlook in United Kingdom to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
11. Reportlinker Adds Drug Delivery Devices Market Outlook in Brazil to 2017 - Metered Dose Inhaler Devices, Infusion Systems, Central Venous Catheters and Needle Free Injections
Post Your Comments:
(Date:11/30/2015)... Wash. , Nov. 30, 2015  Precision ... Post-Processing services, is pleased to announce a dramatic ... medical imaging services. Building on its ISO-9001:2008 certification ... and implemented comprehensive Core Lab protocols and procedures. ... variety of research activities.  Their Core Lab services ...
(Date:11/30/2015)... , November 30, 2015 PFE ... at up to 10 G protein-coupled receptor (GPCR) targets ... to research and develop potential new medicines directed at ... multiple therapeutic areas. --> Heptares Therapeutics ("Heptares"), ... and wholly-owned subsidiary of Sosei Group Corporation ("Sosei"; TSE ...
(Date:11/30/2015)... , November 30, 2015 Mexico Healthcare ... and Life Sciences Report 2015 . --> Pharmaboardroom releases ... . Latin America , a country of ... , a country of over 122 million people. --> ... healthcare, pharmaceuticals, or life sciences insights into the second largest pharma ...
Breaking Medicine Technology:
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today ... Meeting. Their Ecosystem empowers dentists to make complex business decisions by providing the tools ... receive a free fee survey with 10 procedures customized by zip code. , ...
(Date:11/30/2015)... Grove, IL (PRWEB) , ... November 30, 2015 , ... ... for an emerging pharmaceutical company. Because it is so important to this key industry ... “Success Factors in your IND Filing” on December 4th at 11am EST. , Federal ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... has verified that their Vasont Universal Integrator (VUI) extension unites with Syncro Soft’s ... and managing content as a continuous process with the latest release of oXygen® ...
(Date:11/30/2015)... California (PRWEB) , ... November 30, 2015 , ... ... a strategic alliance around Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue ... synthetic polymers, TIGR® Matrix is a long-term resorbable surgical mesh intended to support ...
(Date:11/30/2015)... ... 2015 , ... Healthjump, Inc. announced that it has acquired ... development and support company. The purchase will expand the capability to serve clients ... the services currently provided by Healthjump. , Through this purchase, ...
Breaking Medicine News(10 mins):